Home Compare DGX vs ELV
Stock Comparison · Single-driver result

Quest Diagnostics vs Elevance Health: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Elevance Health carrying a narrow edge on stability. Quest Diagnostics still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Quest Diagnostics, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Elevance Health, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The page question resolves through stability, where Quest Diagnostics Incorporated holds the stronger read even though the broader score still favours Elevance Health, Inc..

Trajectory Similarity
0.75
Similar
Peer-set rank: #8
within Quest Diagnostics Incorporated's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

The clearest structural overlap shows up in margin consistency and investment intensity.

Similarity drivers
margin consistencyinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
DGX
Quest Diagnostics Incorporated
58
Peer-Score
Signal qualityHigh
vs
ELV
Elevance Health, Inc.
61
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: DGX vs ELV Profitability 21 64 Stability 97 32 Valuation 78 85 Growth 44 48 DGX ELV
Gap Ranking
#1 Stability +65
#2 Profitability +43
#3 Valuation +7
#4 Growth +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for DGX and ELV Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer DGXELV Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Quest Diagnostics Incorporated.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
On stability, Quest Diagnostics Incorporated ranks near the top of the group; Elevance Health, Inc. sits in the weaker half.
Profitability
Elevance Health, Inc. sits in the stronger part of the group on profitability, while Quest Diagnostics Incorporated is closer to mid-pack.
Stability — Dominant Gap
DGX
97
ELV
32
Gap+65in favour of DGX

The stability gap is very wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

Quest Diagnostics Incorporated still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Stability points one way, even though the overall score still points the other way.

Explore full peer positioning in AssetNext

Break down the DGX vs ELV comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how DGX and ELV each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.